← All trials
NCT02901288
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Dec 1, 2018
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 3900
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Capital Medical UniversityLead sponsor
- Capital Medical UniversityOverall official - principal investigator
- Capital Medical UniversityReponsible party - principal investigator
- Huazhong University of Science and TechnologyCollaborator
- The Fifth People's Hospital of SuzhouCollaborator
- Changchun Infectious Disease HospitalCollaborator
- Public Health Clinical Center of ChengduCollaborator
- China Medical UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Xinjiang Medical UniversityCollaborator
- Taiyuan Fourth People's HospitalCollaborator
- Infectious Disease Prevention Hospital in Heilongjiang ProvinceCollaborator
- The Third People's Hospital of ZhenjiangCollaborator
- Heilongjiang Province center for tuberculosis Control and PreventionCollaborator
- The Infectious Disease Hospital of Wangkai ZaozhuangCollaborator
- Kaifeng Pulmonary Disease HospitalCollaborator
- The Infectious Hospital of HebiCollaborator
- Pulmonary Hospital of LanzhouCollaborator
- The 4th People's Hospital of Qinghai ProvinceCollaborator
- Tuberculosis Hospital in Jilin ProvinceCollaborator
- Sixth People's Hospital of Nanyang CityCollaborator
- Sixth People's Hospital of NantongCollaborator
- Ningxia Medical UniversityCollaborator
- Tianjin UniversityCollaborator
- Kunming Medical UniversityCollaborator
- Shanxi Medical UniversityCollaborator
- Chongqing Medical UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.